Judge In Acetaminophen Autism/ ADHD MDL Denies J&J’s Preemption Motion

Mealey's (May 2, 2023, 4:19 PM EDT) -- NEW YORK — The New York federal judge overseeing the acetaminophen autism spectrum disorder-attention deficit hyperactivity disorder (ASD-ADHD) multidistrict litigation has denied a motion by Johnson & Johnson Consumer Inc. (JJCI or Johnson & Johnson) to dismiss a mother’s claim on the basis of federal preemption, saying there is no evidence prohibiting additional warnings about the risks to pregnant women....